HardEndocrinologyType 2 diabetes with chronic kidney diseaseau-amcau-racp
A 70-year-old man with type 2 diabetes, CKD stage 3 (eGFR 45 mL/min/1.73 m²) and albuminuria is already on maximally tolerated ACE inhibitor and metformin. His HbA1c is 58 mmol/mol. According to contemporary guidelines, which additional glucose-lowering agent provides proven renal and cardiovascular benefit in this setting?